New Hope in Prostate Cancer Precision Medicine? miRNA Replacement and Epigenetics.
SPINK1 +/ETS - prostate cancer is an aggressive disease with poor clinical outcome. New data suggest a novel treatment by upregulating the expression of miR-338-5p/-421 through epigenetic modulation or by miRNA replacement. This is a new and interesting concept that warrants further exploration in clinical trials.See related article by Bhatia et al., p. 2755.